The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

UW Medicine is unveiling an FDA-approved spinal cord therapy in an effort to offer new hope for paralyzed patients.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Last week, the US Court of Appeals for the Fourth Circuit in United States v. Jackson upheld a doctor’s conviction under Section 301(k) of the ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...

Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment announced today that its groundbreaking device for "providing objective measures of muscle fatigue to ...

Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...